Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이은경 | * |
dc.date.accessioned | 2016-08-27T04:08:16Z | - |
dc.date.available | 2016-08-27T04:08:16Z | - |
dc.date.issued | 2015 | * |
dc.identifier.issn | 1567-567X | * |
dc.identifier.issn | 1573-8744 | * |
dc.identifier.other | OAK-14664 | * |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/217070 | - |
dc.description.abstract | There have been no pharmacokinetic parameters and blood-brain equilibration rate constant (k (e0)) of propofol obtained in a single population of children, by which propofol can be administered using a target effect-site concentration controlled infusion. Thirty-nine, American Society of Anesthesiologists Physical Status 1-2 children aged 2-12 years were given an intravenous bolus of propofol (3 mg kg(-1)), followed by infusion (200 A mu g kg(-1) min(-1)). Arterial drug concentrations and bispectral index (BIS) values were measured. Population pharmacokinetic and pharmacodynamic analysis was performed using nonlinear mixed effects modeling. External model validation was performed in a separate population of children. A two-compartment model and a sigmoid E (max) model directly linked by an effect compartment well described the time courses of propofol concentration and BIS. The estimates of parameters were: V (1) (L) = 1.69, V (2) (L) = 27.2 + 0.929 x (weight - 25), Cl (L min(-1)) = 0.893 x (weight/23.6)(0.966), Q (L min(-1)) = 1.3; E (0) = 76.9; E (max) = 35.4, Ce (50) (mu g mL(-1)) = 3.47 - (0.095 x age) - (1.63 x mean infusion rate of remifentanil in A mu g kg(-1) min(-1)); gamma = 2.1; and k (e0) (min(-1)) = 0.371. Pooled biases (95 % CI) of the target effect-site concentration controlled infusion system of propofol was -20.2 % (-23.3 to -18.1 %) and pooled inaccuracy was 30.4 % (28.6-32.7 %). Pooled biases of BIS prediction was -6.8 % (-9.1 to -4.1 %) and pooled inaccuracies was 19.1 % (17.5-20.9 %).The altered weight-based dose requirements of propofol are well described pharmacokinetically, and pharmacodynamically. Predictive performances of the TCI system in this study were clinically acceptable. | * |
dc.language | English | * |
dc.publisher | SPRINGER/PLENUM PUBLISHERS | * |
dc.subject | Propofol | * |
dc.subject | Pharmacokinetics | * |
dc.subject | Pharmacodynamics | * |
dc.title | Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children | * |
dc.type | Article | * |
dc.relation.issue | 2 | * |
dc.relation.volume | 42 | * |
dc.relation.index | SCI | * |
dc.relation.index | SCIE | * |
dc.relation.index | SCOPUS | * |
dc.relation.startpage | 163 | * |
dc.relation.lastpage | 177 | * |
dc.relation.journaltitle | JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | * |
dc.identifier.doi | 10.1007/s10928-015-9408-2 | * |
dc.identifier.wosid | WOS:000351172300006 | * |
dc.author.google | Choi, Byung-Moon | * |
dc.author.google | Lee, Hyun-Gu | * |
dc.author.google | Byon, Hyo-Jin | * |
dc.author.google | Lee, Soo-Han | * |
dc.author.google | Lee, Eun-Kyung | * |
dc.author.google | Kim, Hee-Soo | * |
dc.author.google | Noh, Gyu-Jeong | * |
dc.contributor.scopusid | 이은경(57188770360;57217075385) | * |
dc.date.modifydate | 20240123125059 | * |